Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1985;85(4):460-3.
doi: 10.1007/BF00429665.

Purine nucleoside--mediated immobility in mice: reversal by antidepressants

Comparative Study

Purine nucleoside--mediated immobility in mice: reversal by antidepressants

S K Kulkarni et al. Psychopharmacology (Berl). 1985.

Abstract

In the forced swimming-induced immobility (despair) test model, adenosine, and 2-chloroadenosine treatment prolonged the immobilization period in mice. Dipyridamole, which is known to inhibit adenosine uptake, potentiated the adenosine effect. The purinoceptor antagonists caffeine and theophylline blocked purine nucleoside-induced enhancement of immobilization. Tricyclic antidepressants such as imipramine and desipramine, the MAO inhibitor tranylcypromine, and amphetamine, a psychostimulant, reversed purine nucleoside-induced immobility. On the other hand, quipazine, fluoxetine, and amitriptyline failed to reverse purine nucleosides-induced prolongation of immobility. None of the antidepressants in the doses investigated had any effect by themselves. Reserpine also prolonged forced swimming-induced immobility in mice. The antidepressants fluoxetine and quipazine, but not methylxanthine pretreatment, reversed reserpine-induced immobility in this test model. These results indicate that adenosine and 2-chloroadenosine probably reduce norepinephrine outflow through their action on presynaptic purinoceptors on noradrenergic neurons and thereby cause prolongation of immobility in animals.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Int Pharmacodyn Ther. 1983 Aug;264(2):180-6 - PubMed
    1. Life Sci. 1981 May 11;28(19):2083-97 - PubMed
    1. Nature. 1957 Nov 30;180(4596):1200 - PubMed
    1. Eur J Pharmacol. 1984 Jan 27;97(3-4):271-5 - PubMed
    1. Eur J Pharmacol. 1969;6(3):274-80 - PubMed

Publication types

LinkOut - more resources